BATHASU
LIVE

Serial Number

79270149

Owner

Qualasept Limited

Attorney

Alexander Lazouski

Filing Date

Jun 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BATHASU Trademark

Serial Number: 79270149 • Registration: 6077255

BATHASU is a trademark filed by Qualasept Limited on June 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Qualasept Limited

3 Corsham Science Park
Corsham, Wiltshire SN13 9FU , GB

Entity Type: 99

Trademark Details

Filing Date

June 18, 2019

Registration Date

June 16, 2020

Published for Opposition

March 31, 2020

Goods & Services

Health education services in the nature of training courses and demonstrations in the field of medical aspects of health; arranging and conducting conferences and seminars in the field of medical aspects of health; conducting educational examinations, assessments and testing in the field of medical aspects of health

Pharmaceutical preparations for the treatment of cancer, autoimmune disease, chronic pain, diabetes, microbial infection, muscle spasticity, asthma, blood disorders and metabolic disorders; medicines for the treatment of cancer, autoimmune disease, chronic pain, diabetes, microbial infection, muscle spasticity, asthma, blood disorders and metabolic disorders; sanitary preparations for medical purposes in the nature of parenteral infusions; dietetic substances for medical use, namely, dietary supplements for parenteral nutrition; plasters, materials for dressings, namely, waddings, gauze, films, foams gels and pastes; disinfectants; fungicides

Medical services; hospital services; nursing and nursing care services; medical and health clinics; health care services; medical, health and fitness assessment services; nursing and care facilities; pharmacy advice regarding information on prescription preparations, side effects and method of use; delivery of healthcare services; provision of healthcare services at patients' residences; pharmacy services, namely, prescription preparation; advice, information and consultancy services relating to all the aforesaid services

Medical research services; health research services; biological research services; bio-technology research services; provision of scientific and industrial pharmaceutical research services; pharmaceutical research and development for others; provision of scientific and technological pharmaceutical services and research; advice, information and consultancy services relating to all the aforesaid services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 16, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 15, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 1, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 2, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 8, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 8, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 16, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2020 NONP
ASSIGNED TO EXAMINER
Mar 2, 2020 DOCK
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 25, 2020 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2020 CRFA
ASSIGNED TO LIE
Feb 19, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 21, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 21, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 1, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 31, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 29, 2019 MAFR
ASSIGNED TO EXAMINER
Oct 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2019 REPR